Latest filing published 31 Mar 2026 for Volato Group, Inc., €2,254.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -87.9%Entry US$15.99 · Close at T+365 US$1.93
- -75.6%Entry US$2.05 · Close at T+365 US$0.50
- -43.7%Entry US$1.65 · Close at T+365 US$0.93
- -37.6%Entry US$1.44 · Close at T+365 US$0.90
- -54.1%Entry US$1.96 · Close at T+365 US$0.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark Heinen: trading record in brief
This profile gathers the share dealings of Mark Heinen across 2 companies, led by Better Therapeutics, Inc. and Volato Group, Inc. Over a trading history stretching from 28 October 2021 to 27 March 2026, the count stands at 15 filings.
Every open-market trade on record is a purchase: 9 purchases worth €137k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants.
The median purchase comes to €7,345. Of 7 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 7 purchases old enough to measure, the stock rose over the following 90 days in 29% of cases; the median change was -31.7%. These figures describe past trades and do not predict future prices.
On 31 March 2026 came the latest disclosure, a share grant for €2,254 in Volato Group, Inc. The last purchase on record was published on 10 June 2024, which is 881 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark Heinen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.2626.5% of flowCommon StockSEC:0001628280-26-022229:0
- 45,000 shares0Common StockSEC:0001628280-25-024366:0
- 139,463 shares0Common StockSEC:0001628280-24-027731:0
- 8,500 shares@ US$0.8073.5% of flowCommon StockSEC:0001628280-24-027587:0Canonical exit: 4 Sept 2024 (T+90)
- 54,000 shares0Common StockSEC:0000950170-23-013898:0
- 15,723 shares@ €1.20221.1% of flowCommon StockSEC:0000899243-22-037417:0
- 23,868 shares@ US$1.9467.0% of flowCommon StockSEC:0000899243-22-031045:0Canonical exit: 11 Dec 2022 (T+90)
- 26,132 shares@ US$1.940.0% of flowCommon StockSEC:0000899243-22-031045:1Canonical exit: 12 Dec 2022 (T+90)
- 2,280.605 shares@ US$1.753969.75% mcap61.2% of flowCommon StockSEC:0000899243-22-024391:0Canonical exit: 22 Sept 2022 (T+90)
- 5,000 shares@ US$1.5610.8% of flowCommon StockSEC:0000899243-22-021998:0Canonical exit: 8 Sept 2022 (T+90)
- 5,000 shares@ US$1.9813.1% of flowCommon StockSEC:0000899243-22-013344:0Canonical exit: 29 Jun 2022 (T+90)
- 500 shares@ US$5.44Common StockSEC:0000899243-21-048374:1Canonical exit: 14 Mar 2022 (T+90)
- 2,333 shares@ US$4.70Common StockSEC:0000899243-21-048374:2Canonical exit: 15 Mar 2022 (T+90)
- 500 shares@ US$5.4538.8% of flowCommon StockSEC:0000899243-21-048374:0Canonical exit: 13 Mar 2022 (T+90)
- 6,667 sharesCommon StockSEC:0000899243-21-042247:0
15 of 15 declarations
